Skip to content
  • Home
  • How We Work
    • The Impact of Autophagy in Health and Disease
    • Biophagy’s Business Model
    • Biophagy’s Proprietary Drug Development
    • Cell Watchᵀᴹ
  • Business Development
  • Background & News
  • Team
  • Contact
Previous Next

Biophagy, working with Sandia National Laboratories, is awarded an individual company grant from NMSBA to study the binding sites and autophagy stimulating activities of several UNM compounds under consideration for licensing.

By jordan|2022-03-22T20:39:42+00:00February 1, 2022|2016-announcements|0 Comments

Share This Story, Choose Your Platform!

FacebookTwitterRedditLinkedInWhatsAppTelegramTumblrPinterestVkXingEmail

About the Author: jordan

Related Posts

  • Biophagy opens a second office in Mountainair, NM

    Biophagy opens a second office in Mountainair, NM

  • Albuquerque Business First awards Dr. Mary Ortner, Biophagy’s CEO, its Woman of Influence award in recognition of her contributions to business development in Albuquerque.

    Albuquerque Business First awards Dr. Mary Ortner, Biophagy’s CEO, its Woman of Influence award in recognition of her contributions to business development in Albuquerque.

Leave A Comment Cancel reply

Copyright 2022 | All Rights Reserved | Website Design and Development by Ingenuity Software Labs
FacebookTwitterInstagramPinterest
Page load link
Go to Top